Materialise NV (MTLS) shares plummeted 6.72% in pre-market trading on Thursday, following the release of the company's fourth quarter and full year 2024 financial results. The 3D printing software and services provider reported mixed results that missed revenue estimates and provided a lackluster outlook for 2025.
For Q4 2024, Materialise reported revenue of €65.68 million, falling short of analysts' estimates of €71.50 million. While the company's Medical segment continued its growth trajectory with a 14.3% increase in revenue, the Manufacturing segment saw a 13.3% decline due to persistent macroeconomic headwinds in the European industrial sector.
Looking ahead to 2025, Materialise expects revenue growth to be driven primarily by its Medical segment, while its Software segment's transition to a cloud-based subscription model could impact revenue potential. The company anticipates continued challenges in the European industrial market, impacting the performance of its Manufacturing segment. Materialise forecasts full-year 2025 revenue in the range of €270 million to €285 million and Adjusted EBIT between €6 million and €10 million, reflecting increased depreciation charges.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。